1. Home
  2. NEON vs CVM Comparison

NEON vs CVM Comparison

Compare NEON & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.70

Market Cap

27.9M

Sector

Technology

ML Signal

HOLD

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$2.31

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
CVM
Founded
1997
1983
Country
Sweden
United States
Employees
N/A
44
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
19.3M
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
NEON
CVM
Price
$1.70
$2.31
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
84.5K
63.4K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
N/A
EPS
N/A
N/A
Revenue
$3,108,000.00
$264,033.00
Revenue This Year
$72.74
N/A
Revenue Next Year
$28.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
65.45
52 Week Low
$1.27
$0.23
52 Week High
$29.90
$13.48

Technical Indicators

Market Signals
Indicator
NEON
CVM
Relative Strength Index (RSI) 60.66 29.63
Support Level $1.69 N/A
Resistance Level $1.74 $4.84
Average True Range (ATR) 0.10 0.31
MACD 0.02 -0.15
Stochastic Oscillator 88.57 1.85

Price Performance

Historical Comparison
NEON
CVM

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: